Recent advances in the molecular signaling pathways of Substance P in Alzheimer's disease: Link to neuroinflammation associated with toll-like receptors

被引:3
|
作者
Gurram, Prasada Chowdari [1 ,2 ]
Satarker, Sairaj [1 ]
Nampoothiri, Madhavan [1 ]
机构
[1] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Dept Pharmacol, Manipal 576104, Karnataka, India
[2] Koneru Lakshmaiah Educ Fdn, KL Coll Pharm, Vaddeswaram 522302, AP, India
关键词
Substance P; Alzheimer's disease; TLR; Neurokinin; Neurodegeneration; Neuroinflammation; AMYLOID PRECURSOR PROTEIN; MESSENGER-RNA EXPRESSION; NEUROKININ-1; RECEPTOR; IMMUNE-SYSTEM; TACHYKININS; CELLS; PEPTIDE; IMMUNOREACTIVITY; INTERLEUKIN-6; MODULATION;
D O I
10.1016/j.bbrc.2024.150597
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A significant quantity of substance P (SP) and its receptor, the neurokinin 1 (NK1) receptors are found in the brain. SP is a neuropeptide distributed in the central nervous system and functions as a neurotransmitter, neuromodulator, and neurotrophic factor. The concentrations of SP in the brain and cerebrospinal fluid fluctuate in individuals with Alzheimer's disease (AD). SP is an endogenous ligand for NK1 receptor, enhancing the expression of toll-like receptors (TLR) and vice versa. So, both pathways are interconnected, where activation of one pathway activates the second pathway. Researchers have observed the interaction of TLR with SP in the pathophysiology of AD. Thus, this review discusses various TLRs involved in regulating amyloid processing and its interaction with SP in AD. Further, in AD pathology, SP can regulate the non-amyloidogenic pathway. Recent studies have also demonstrated the capacity of SP in regulating voltage-gated potassium channel currents, emphasizing SP's neuroprotective ability. Therefore, we corroborate the findings linking the SP, NK1R, and TLRs in AD.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Role of toll-like receptors in multiple myeloma and recent advances
    Thakur, Krishan K.
    Bolshette, Nityanand B.
    Trandafir, Cristiana
    Jamdade, Vinayak S.
    Istrate, Alexandru
    Gogoi, Ranadeep
    Cucuianu, Andrei
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (03) : 158 - 167
  • [22] Expression of Toll-like Receptors and Their Signaling Pathways in Rheumatoid Synovitis
    Tamaki, Yasunobu
    Takakubo, Yuya
    Hirayama, Tomoyuki
    Konttinen, Yrjo T.
    Goodman, Stuart B.
    Yamakawa, Mitsunori
    Takagi, Michiaki
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (05) : 810 - 820
  • [23] Important aspects of Toll-like receptors, ligands and their signaling pathways
    Z. L. Chang
    Inflammation Research, 2010, 59 : 791 - 808
  • [24] Important aspects of Toll-like receptors, ligands and their signaling pathways
    Chang, Z. L.
    INFLAMMATION RESEARCH, 2010, 59 (10) : 791 - 808
  • [25] Immune Mechanisms in Alzheimer's Disease: The Role of Toll-Like Receptors Signalling
    Sharma, Dinisha
    Manjunatha, P. M.
    Babu, T. Hari
    Dhungel, Arpan
    Swaraj, Sushree
    Janadari, Suresh
    Sharma, Uday Raj
    Surendra, V.
    Taj, Nageena
    Gayathri, S. V.
    CURRENT PHARMACOLOGY REPORTS, 2024, 10 (06) : 267 - 276
  • [26] Recent Advances in Studying Toll-like Receptors with the Use of Computational Methods
    Bzowka, Maria
    Bagrowska, Weronika
    Gora, Artur
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (12) : 3669 - 3687
  • [27] Molecular Interactions in Interleukin and Toll-like Receptor Signaling Pathways
    Snyder, Greg A.
    Sundberg, Eric J.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (08) : 1244 - 1258
  • [28] Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals
    Vidya, Mallenahally Kusha
    Kumar, V. Girish
    Sejian, Veerasamy
    Bagath, Madiajagan
    Krishnan, Govindan
    Bhatta, Raghavendra
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2018, 37 (01) : 20 - 36
  • [29] Microbiota-gut-brain axis and toll-like receptors in Alzheimer's disease
    Lin, Caixiu
    Zhao, Shuai
    Zhu, Yueli
    Fan, Ziqi
    Wang, Jing
    Zhang, Baorong
    Chen, Yanxing
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2019, 17 : 1309 - 1317
  • [30] Advances in molecular agents targeting toll-like receptor 4 signaling pathways for potential treatment of sepsis
    Zheng, Yunyun
    Gao, Yingying
    Zhu, Weiru
    Bai, Xian-guang
    Qi, Jinxu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 268